Samsung Biologics Co Ltd

CUSIP: 00BYNJCV6

Samsung Biologics Co Ltd — institutional ownership and SEC 13F holdings data. Source: SEC EDGAR 13F filings.

Market Cap
-
Sector
-
Institutional Owners
0
Institutional Value
-

About

Samsung Biologics is a South Korea–based contract development and manufacturing organization (CDMO) that provides development, analytical, and large-scale commercial manufacturing services for biologic drugs, including monoclonal antibodies and recombinant proteins. As an affiliate of the Samsung group, it operates multiple large biomanufacturing facilities in Songdo and serves global pharmaceutical and biotech clients with end-to-end process development, quality control, and sterile fill/finish capabilities, positioning it among the leading global CDMOs for biologics.

Institutional Holders

Loading...

Source: SEC EDGAR 13F-HR filings from institutional investment managers.